OligoG: study halt and redesign
The recent news about the EU approval of Kaftrio is truly great news for the many people with cystic fibrosis (CF) who will be eligible for treatment with this new […]
CTN annual report 2019 now available
The ECFS Clinical Trial Network has just published its 2019 annual report. In the 2019 ECFS Clinical Trial Network annual report, you will find more information about the activities of […]
ECFS / CF Europe awarded three Post-Doctoral Research Fellowships!
With the aim to foster basic and translational research on CF, the ECFS and CF Europe organised a joint call for applications for their new Post-Doctoral Research Fellowship programme. > […]
First site initiation for OligoGpivotalCF in Austria
OligoGpivotalCF is about to start! On 6 May 2020 the first site was initiated in Wels, Austria, and more site initiation visits are planned for the coming months. Pending the […]
A multinational report to characterise SARs-CoV-2 infection in people with cystic fibrosis
Authors: Rebecca Cosgriffa, Susannah Ahernb, Scott C. Bellc, Keith Brownleea, Pierre-Régis Burgeld, Cass Byrnese, Harriet Corvolf, Stephanie Y. Chengg, Alexander Elberth, Albert Faroh, Christopher H. Gossi, Vincent Gulmansj, Bruce […]
OligoGpivotalCF and Covid-19
AlgiPharma CF Clinical Trial Operations in Europe on hold Regulatory and ethical approvals have been received from Austria and UK, and approvals are expected to follow soon in Germany and […]
Young Investigators give research a breath of fresh air!
The European Young Investigators Meeting of cystic fibrosis (CF) researchers was held in Paris at the end of February. It was hosted by the French CF Association ‘Vaincre la Mucoviscidose’ […]
First phase of the HIT-CF-Europe project completed successfully
Today, CF Europe is proud to announce, on behalf of the HIT-CF consortium, the successful completion of the first phase of the project with the collection of biopsies from 502 […]
HIT CF – project launched!
In January 2018 the HIT CF project kicked off. This European project brings together researchers, doctors, pharmaceutical companies and patient representatives with the aim to develop ‘personalized treatments’ for Cystic […]
New at-a-glance report of the ECFS-PR online
The ECFS-PR has launched its at-a-glance report 2015 with key information of the Annual Report, designed for people with CF and their families. You can find the at-a-glance report here: […]